Please Wait

Applying Filters...

Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector April 2025: Merck KGaA buys SpringWorks for US$ 3.9 bn; Swiss giants lead pharma migration to US soil

Stock Recap
#PipelineProspector

Octreotide Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 27 USDMF, 9 CEP/COS, 4 JDMF, 5 EU WC, 1 KDMF, 20 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers, 61 FDA Orange Book, 92 Europe, 11 Canada, 48 Australia, 8 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 2 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 3 Granulation, 1 Solubilizers, 1 Topical, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 39 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 79 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

18 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

6 Others

6 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
25/04/2025	Bachem AG	Switzerland	Bachem AG Bubendorf CH	R0-CEP 2020-229 - Rev 01	Octreotide	2022-07-18	Valid	Chemical		2414
25/04/2025	Auro Peptides Limited	India	AURO PEPTIDES LIMITED Kandi Mandal IN	CEP 2023-017 - Rev 00	Octreotide	2025-03-28	Valid	Chemical		2414

Contact us
to update this info

Octreotide Acetate

Octreotide Acetate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

27 USDMF

9 CEP/COS

4 JDMF

5 EU WC

1 KDMF

20 NDC API

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers

61 FDA Orange Book

92 Europe

11 Canada

48 Australia

8 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

1 Faran Shimi Pharmaceutical

1 Gangwal Healthcare

1 Pfanstiehl

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

2 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

11 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

7 Parenteral

7 Disintegrants & Superdisintegrants

5 Co-Processed Excipients

3 Granulation

1 Solubilizers

1 Topical

1 API Stability Enhancers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

39 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

79 Regulatory FDF Prices

10 Annual Reports

MARKET PLACE

18 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents

1 US Exclusivities

REF. STANDARDS & IMPURITIES

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons